Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 900
Avg Vol 1,792
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 29%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Swedish Orphan Biovitrum AB (publ), a biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia. The company operates through three segments: Haematology, Immunology, and Specialty Care. It offers Alprolix for haemophilia B; ALTUVOCT for the treatment and prophylaxis of bleeding in patients with haemophilia A; Aspaveli/Empaveli for treating adult patients with paroxysmal nocturnal haemoglobinur...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 46 86 97 20 00
Address:
Norra Stationsgatan 93A, Stockholm, Sweden
Latest News on SWOBY
No data available.